Li Yan-Ping, Wang Ya-Ting, Wang Wen, Zhang Xiao, Shen Ren-Juan, Jin Kangxin, Jin Li-Wen, Jin Zi-Bing
Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China.
Quanzhou Aier Eye Hospital, Quanzhou 362017, China.
PNAS Nexus. 2022 Aug 17;1(4):pgac162. doi: 10.1093/pnasnexus/pgac162. eCollection 2022 Sep.
Retinoblastoma (Rb) is a type of malignant tumor due to abnormal retinogenesis with biallelic mutations of the gene. Its pathogenesis has been proposed as a "two-mutation hypothesis" by Knudson since 1971; however, there remain some debates on disease onset sufficiency of the biallelic mutations. To obtain straightforward evidence for this hypothesis, we investigated whether two-hit mutations of the gene drive tumorigenesis in patient-induced pluripotent stem cell (hiPSC)-derived human retinal organoids (hROs) and whether single allelic mutation hiPSC-derived hROs exhibit molecular and cellular defects. We generated hiPSCs with a heterozygous germline mutation ( ) from a Rb patient. A second-allele gene mutation was knocked in to produce compound heterozygous mutations ( ) in the hiPSCs. These two hiPSC lines were independently developed into hROs through a stepwise differentiation. The hiPSC- derived organoids demonstrated tumorigenesis in dishes, consistent with Rb profiles in spatiotemporal transcriptomes, in which developmentally photoreceptor fate-determining markers, CRX and OTX2, were highly expressed in hiPSC- derived hROs. Additionally, ARR3 maturing cone precursors were co-labeled with proliferative markers Ki67 or PCNA, in agreement with the consensus that human Rb is originated from maturing cone precursors. Finally, we demonstrated that retinal cells of hROs with monoallelic mutation were abnormal in molecular aspects due to its haploinsufficiency. In conclusion, this study provides straightforward supporting evidence in a way of reverse genetics for "two-hit hypothesis" in the Rb tumorigenesis and opens new avenues for development of early intervention and treatment of Rb.
视网膜母细胞瘤(Rb)是一种由于基因双等位基因突变导致视网膜生成异常的恶性肿瘤。自1971年以来,Knudson提出其发病机制为“双突变假说”;然而,关于双等位基因突变在疾病发病中的充分性仍存在一些争议。为了获得这一假说的直接证据,我们研究了基因的两次打击突变是否驱动患者诱导多能干细胞(hiPSC)来源的人视网膜类器官(hROs)发生肿瘤igenesis,以及单等位基因突变的hiPSC来源的hROs是否表现出分子和细胞缺陷。我们从一名Rb患者中生成了具有杂合种系突变( )的hiPSC。通过敲入第二个等位基因 基因突变,在hiPSC中产生复合杂合突变( )。这两个hiPSC系通过逐步分化独立发育成hROs。hiPSC来源的类器官在培养皿中显示出肿瘤igenesis,与时空转录组中的Rb特征一致,其中发育性光感受器命运决定标记物CRX和OTX2在hiPSC来源的hROs中高度表达。此外,ARR3成熟视锥前体细胞与增殖标记物Ki67或PCNA共标记,这与人类Rb起源于成熟视锥前体细胞的共识一致。最后,我们证明了单等位基因 突变的hROs的视网膜细胞由于其单倍体不足在分子方面异常。总之,本研究以反向遗传学的方式为Rb肿瘤igenesis中的“双打击假说”提供了直接的支持证据,并为Rb的早期干预和治疗开辟了新途径。